Lexington Announces First Multicenter Clinical Study Site
21. August 2018 09:00 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...